chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hives around her neck.; dull headache; soreness in arm; This is a spontaneous report from a contactable Nurse (patient, self-reported). A female patient with unspecified age units received of bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number and expiry date were not provided), via an unspecified route of administration on 03Mar2021, Wednesday at 10:00, as a single dose for covid-19 immunisation. The patient's medical history and concomitant medication were not reported. On 04Mar2021, yesterday, patient experienced dull headache and soreness in arm. On 05Mar2021, today, the patient experienced hives around her neck. She wants to know if this was reported as a side effect of vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Suspected myocardial infarction on 01/15/2021.  Patient passed away on 01/15/2021.
after one week patient developed rash and presented to dermatologist and was placed on prednisone.  After being on prednisone for one week patient passed out at a friend's house and 911 was called.  Patient did not go to ER because vitals were normal, but patient complained of "weird" tongue feeling and said that there were sores in the mouth as well.  She is still currently on prednisone and recovering.
I am diabetic, started feeling very tired and sleepy and I had to lay down before doing daily activities. I thought it was my blood pressure medication and I have lost weight on purpose with the help of my doctor, so it triggered me to think it was the new blood pressure medication. Did a zoom call with my PCP and she did want me to come in, saw her on 05/17/2021. Saw my endocrinologist on 05/11/2021 and wanted me to follow up with my PCP. I don't feel it has resolved. Had EKG with blood work and stress test. Doctors report says my heart was remarkable.
Patient presented to ED with weakness, black stool and was found to have erosive gastritis with PUD. Multiple polyps on colonoscopy. Per , hospitalizations are to be reported irrespective of attribution to the vaccine. This hospitalization does not appear to be related to the vaccine.
Headaches, severe muscle aches, nausea, injection site pain everyday since the shot.
A nurse reported that a 40 year old female received an injection of Pnu-Imune 23 on 4/6/01. That same day, she developed an injection site reaction characterized by a 30mm area of redness and induration and inability to move her arm. She experienced nausea and vomiting and developed a fever of 101F. She recovered. No further information was available at the date of the report. This is 1 of 4 pts from this facility who experienced these events following receipt of Pnu-Imune 23, lot 469401. (See HQ9560211APR2001, HQ1777307JUN2001 and HQ1777507JUN2001).
Loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Idiopathic pulmonary fibrosis. Concomitant products included PIRFENIDONE (ESBRIET) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite). At the time of the report, DECREASED APPETITE (Loss of appetite) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details were not provided.
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 25-SEP-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 2.5 ml/five dose vial, lot # K007773 and expiration date 01-MAY-2015 (administration route was not provided). No adverse effects were reported. The vaccine had one temperature excursion of 48 hours with a lowest recorded temperature of 1 Fahrenheit (F) (1 Celsius (C)). The storage criteria and the type of excursion for this vaccine was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Cellulitis at site of immunization with Tetanus vaccine. Excellent response to antibiotic rx.
Pt Felt faint and dizzy while sitting in chair after receiving her vaccine. Was able to lay in a supine position on cot. Vital signs obtianed and WNL as noted.  Pt encouraged to sip fluids. Pt reported feeling better and was able to sit up with VS remaining stable. Stood and ambulated freely. Discharged home after additional observation without incident
Was administering 0.2ml dose for patient. Patient was being help on father's lap and child pulled away so hard and fast that needle was removed from arm and slid back into another location to the right of the original puncture. I immediately removed needle and HAD NOT administered ANY of the vaccine. I could not confirm where the needle location was so I did not administer.
Dr. asked I give patient a Hepatitis B vaccine and in error I gave Hepatitis A vaccine.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 44-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Alcoholism (1 glass of wine a day) in 1995. Concurrent medical conditions included Mental disorder (It is improving) since 1998. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy, LEVOTHYROXINE for Thyroid disorder.    On 08-Mar-2021 at 11:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 06-Dec-2020 and the estimated date of delivery was 12-Sep-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Acute ischemic stroke. Presented 7/20 with acute onset left sided weakness, slurred speech, facial droop and was found to have right MCA occlusion. She was outside the time window for TNK but did receive IR therapy with thrombectomy and successful recanalization.
Patient here to report vaccine adverse event. Patient received 1st dose of Moderna vaccine 01/16/2021 within 48 hours experienced pain in the muscle behind left thigh (pain 6/10) .  5-6 days later experienced body aches with stabbing, pins and needles sensation that traveled throughout different parts of his body mainly upper and lower extremities, shoulders, and chest.  Over weeks pain gradually  decreased, however, continues to have mild pain and pain of left leg and thigh 2/10. February, 2021 had 2nd Moderna vaccine a few days later experienced bilaterally upper and lower arm and leg pain with sensitivity to touch. Also experience intermittent sharpe shoulder pain that last 30 minute 4/10. Reports pain is always there.Was seen by PCP for evaluation of symptoms and was prescribed oxycodone for the pain. During that time patient changed PCP and was evaluated for the symptoms and prescribed Tramadol. Patient has f/u appt with PCP 22 April 2021. Patient is not sure if side effects were reported by PCP.  Patient has history SS  Last SS crisis 1 year ago. Reports pain is different from ss pain.
Developed light rash to chest approximately 10 min after receiving flu vaccine. Total lesions approx 1 dozen to torso. No respiratory involvement. Gave 1/2 tsp of BENADRYL in office. Same reaction when child received flu vaccine Dec 2013. Gave BENADRYL then also. Rash resolved.
After receiving my first shot in the afternoon I felt really well. When I woke up the following morning I had noticeable ringing in both of my ears. I had never had this before. Prior to receiving my second dose I consulted with the on-site doctor about my concern the ringing could increase with the second dose...she thought the chances of that happening were extremely low and hadn?t heard of my side-effect from the vaccine yet. I got the second dose and the ringing did get louder over time.
After a week of COVID vaccine administration (Moderna) and 5 days without discomfort and redness, the patient presented pain, warm, itching and redness in the injection area. In addition, she presented nausea and a lot of fatigue.  Her doctor recommended to take Benadryl, ice in the area and keep on observation. The next day the patient woke up better.
(L) arm redness and swelling treated with cellulitis w/Keflex x 7 d.
extreme tiredness, Malaise with body and joint aches, asthma minor flare up, wheezing that woke me up during the night. Sore L upper arm
Extreme body aches  severe headaches Nausea vomiting confusion dizziness fever of 101.6-102.2 for > 24 hours injection site pain axillary lymphadenopathy
A nurse reported that a 45 year old female received Pnu-Imune 23 on 11/8/99 and within 24 hours, developed an injection site reaction characterized by redness, pain and swelling, "bigger that" her "fist". This is 1 of 4 pts from this facility who experienced an injection site reaction following receipt of Pnu-Imune 23 lot 463016 or 458476. The reporter indicated that 4 pts experienced an injection site reaction; however, only 1 is presently identifiable. Additional reports will be generated when identifying information is provided. Additional information received on 1/17/00, indicated that the pt recovered.
Had diarrhea from 8/16/2017-8/21/2017.
herpes zoster; Information has been received on from a lawyer and a female patient (pt) of unknown age. No information was provided regarding the pt's medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications. On or about 14-FEB-2017, the pt was inoculated, by a healthcare provider, with Zoster Vaccine Live (ZOSTAVAX) (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions.  On an unspecified date (reported as "subsequent to inoculation"), the pt was treated by a healthcare provider for herpes zoster. As a direct and proximate result of the Zoster Vaccine Live (ZOSTAVAX) the pt suffered ongoing injuries including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. At the reporting time, the outcome of the event was not recovered and the causality was related.
Patient seen today 09/26/2018 for allergic reaction (hives all over body) to FLUBLOK given 09/24/2018 started medication today.
Sat night-hives on  both arms and chest, Monday day- hives on both arms and vagina, Tuesday evening- rash on chest and neck - took Zyrtec each time
Client was given BOOSTRIX (Tdap) on Wed. 5/9/12. By Thursday she noted a bump on her (R) deltoid site where the vaccine had been injected. By the weekend it was sore, tender and was the size of a dime. Today Monday, 5/14/12, it is still about dime-sized, red, raw at the vaccination site. She state it's still somewhat sore.
5 days p/vax pt inc temp x 3 days; highest measurement 103.2; no redness, swelling etc; rash on trunk x 3 days, crying/staring episodes crying x 6, staring x 1 were felt to be convuls;
On 8-29-19, patient's mother called us to report an increased heart rate to 212/min and oxygen desaturation to 83% During a feeding, he desaturated to 79% for four minutes. Mother called patient's neurologist to see what their thoughts were. His neurologist increased the seizure medication (trileptal) He did not have any further issues after this.
pt recvd vax & 5 months p/vax was dx w/thrombocytopenia;
Infection given on 5/26/12. Pt reported she developed a rash on 5/27/12 she presented at pharmacy on 5/29/12 to show us redness in area of vaccine pt. is still recovering.
Information has been received from an office staff in physician office concerning a 63 year old female patient with a history of Fibro Myalgia who was vaccinated with ZOSTAVAX. A couple days later after receiving ZOSTAVAX the patient experienced neuralgia on the right side of her head and face. The patient saw the physician for medical attention. At the time of reporting, the patient recovered from the adverse effect. Additional information has been requested.
Pt seen on 9/7 with multiple chicken like spots (papules) on torso, arms, leg
Dizzy spells when patient gets out of bed or when he sits or stands from sitting position; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy spells when patient gets out of bed or when he sits or stands from sitting position) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and LOT040B21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, HYDROCHLOROTHIAZIDE and SIMVASTATIN for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced DIZZINESS (Dizzy spells when patient gets out of bed or when he sits or stands from sitting position). At the time of the report, DIZZINESS (Dizzy spells when patient gets out of bed or when he sits or stands from sitting position) outcome was unknown.            Concomitant products included lisinopril, hydrochlorothiazide and simvastatin for unknown indication   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up received on 27-5-21 via TCR.Denied further follow up
Patient reported feeling funny and then fainted for a couple of minutes.  When he regained consciousness he was sweating profusely.
Covid arm. Raised red welt on day 11 with pain; Covid arm. Raised red welt on day 11 with pain; very painful into shoulder blade; still painful into neck as well; Red circle around injection site; This is a spontaneous report from a contactable consumer. This 59-years-old non-pregnant female consumer (Patient) received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration, administered in arm right on 19Feb2021 02:45 PM (Batch/Lot Number: EN6203) as SINGLE DOSE for covid-19 immunisation. Medical history included known allergies: Penicillin. The patient's concomitant medications were not reported. No other vaccine in four weeks. The patient experienced covid arm, raised red welt on day 11 with pain, very painful into shoulder blade, still painful into neck as well and red circle around injection site; all on 02Mar2021 at 04:00 PM. It was reported that Covid arm. Raised red welt on day 11 with pain. Better day 2, 3 day very painful into shoulder blade. Day 4 still painful into neck as well. Red circle around injection site. No treatment was received. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
SIRVA- Pain in shoulder with and without use.  Taking nsaids pain is still occurring.
Fever; chills; headache; nausea; stomach irritation; throat irritation; shoulder pain; This is a spontaneous report received from a contactable consumer from a Pfizer sponsored program. A female patient of an unspecified age received second dose of BNT162B2 (Pfizer COVID-19 Vaccine: Solution for injection; Batch/Lot number: unknown), dose 2 via an unspecified route of administration on 12Mar2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 on an unspecified date for covid-19 immunisation. On an unspecified date patient had experienced fever, chills, headache, nausea, stomach and throat irritation and shoulder pain. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Patient had headache after first day and swollen lymph nodes receiving 3rd covid booster(Pfizer); Patient had headache after first day and swollen lymph nodes receiving 3rd covid booster(Pfizer); headache; swollen lymph nodes; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient) received by Pfizer from Sanofi. A 16-years-old male patient received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation, Dupilumab (DUPIXENT, Solution for injection, Batch/Lot number and expiry date not reported) via subcutaneous route from 04Jun2020 and ongoing, at 300 mg, every other week for severe persistent asthma, uncomplicated. Medical history included Asthma, family history was not reported. Concomitant medications included formoterol fumarate, mometasone furoate (DULERA), Salbutamol (ALBUTEROL HFA), Montelukast (MONTELUKAST) taken for an unspecified indications, start and stop date were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation and then took second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. On an unspecified date, the patient experienced headache after first day and swollen lymph nodes. It was not reported if the patient received a corrective treatment for the events. The action taken for Dupilumab was dose not changed. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Hot, red, swollen right arm - Swollen from shoulder to below elbow. Treatment of ORAPRED (oral steroid) and cepnallxin (antibiotic for skin infection).
pt recvd vax; pt found dead on 28oct94 in crib by father at 10:30am; full autopsy pending; t at time of vax 99.6 rectally;
My supervisor advised me to fill out form due to there being 2 vials on our basket the day of vaccinating patient. She is unsure if one of the vials was expired from the day before.
Slight throat tightening, headache, muscle ache, fatigue, swelling in arm for over a week, itching in arm since 5th day
choking sensation & throat closed; chest felt tight; given Epi; sx did not resolve; transported to ER; treated w/more medication; clinically stable in 2 hrs;
About 24 hours after shot, client's left upper arm became red, swollen, hot and itchy. Redness size of half dollar. No fever. Client scratching site. Mother wrapped ice pack in towel, plus administered Tylenol. 1/3/05 Follow up call to mom; child fine after 24 hours and more Tylenol. No MD visit needed.
Patient was 16 years old when they received the Johnson & Johnson vaccine (at the time, this vaccine was only approved for 18 years and older).  Patient did not experience any notable side effects other than a headache the next day.
pt recvd vax & exp flu-like sx which progressed to transverse myelitis;
Sore arm, then around 8:00 pm the same day I came down with muscle aches, chills, low grade fever, head ache, nausea.
No adverse events until 10:30 pm next day. Got up from relaxing position suddenly felt dizzy, laid down on floor - proceeded to passed out momentarily - tried to get up and momentarily passed out again. Rested for approximately 3/4 hours and then was ok. No events since.
About 5-7 days after vaccination patient started having symptoms she reported as  right sided facial numbness also had pain and headache. Patient did also report localized reaction of redness and hives around injection site along with fever 0- the time frame on this.  Patient did report to the emergency department and had a workup but no definitive diagnosis was identified.   On 2/10/21: Patient reports for the most part this has significantly improved and continues to although still some residual numbness
COVID-19; COVID-19; FACILITATED COLLECT  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4257283-00.  A 39 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administration date 2021 (Batch/Lot number: unknown) as dose 1, single and intramuscular, administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) at citrate free for psoriasis. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (non-serious) with onset Mar2021, outcome "unknown", described as "COVID-19";DRUG INEFFECTIVE (serious) with onset Aug2021, outcome "unknown", described as "Flu like symptoms after second covid vaccination". The action taken for adalimumab was unknown.  Additional information: Events of non-serious COVID-19 and flu like symptoms after second covid vaccination with Humira (adalimumab). It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Patient took Booster on 03Aug 2021.  Causality assessment for Drug HUMIRA (Solution for injection in pre-filled pen) (ADALIMUMAB): Event Covid 19 and Flu like symptoms, As per reporter:Not Reported. Dechallenge: N/A. Causality assessment for PFIZER BIONTECH COVID-19: Event Covid 19, As per reporter:Not Reported and for event Flu like symptoms, as per reported: Possible, Dechallenge:  N/A.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded.,Linked Report(s) : US-PFIZER INC-202200268978 same patient/vaccine, different dose /event